Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2007-04-03
2007-04-03
O'Hara, Eileen B. (Department: 1646)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S361000, C435S252300, C435S254200, C536S023500, C530S350000
Reexamination Certificate
active
10243157
ABSTRACT:
The present invention is directed to novel polypeptides having homology to members of the tumor necrosis factor receptor family and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 6812339 (2004-11-01), Venter et al.
patent: 307247 (1989-03-01), None
patent: 417563 (1991-03-01), None
patent: WO 97/01633 (1997-01-01), None
patent: WO 97/25428 (1997-07-01), None
patent: WO 98/18921 (1998-05-01), None
patent: WO 98/28426 (1998-07-01), None
patent: WO 99/19490 (1999-04-01), None
patent: WO 00/01817 (2000-01-01), None
patent: WO 00/53758 (2000-09-01), None
Vukicevic et al., 1996, PNAS USA 93:9021-9026.
Amakawa et al., “The Hodgkin Disease Antigen CD30 is Crucial for Antigen-Induced Death of Developing T Cells”Symposium on Programmed Cell Death(Abstract No. 10), Cold Spring Harbor Laboratory (1995).
Armitage et al., “Molecular and Biological Characterization of a Murine Ligand for CD40.”Nature. 357(6373) :80-82 (1992).
Ashkenazi and Dixit., “Death Receptors: Signaling and Modulation.”Science. 281(5381) :1305-1308 (1998).
Ashkenazi et al., “Protection Against Endotoxic Shock by a Tumor Necrosis Factor Receptor Immunoadhesin”Proc. Natl. Acad. Sci. 88:10535-10539 (1991).
Baldwin, A., “The NF-kB and IkB Proteins: New Discoveries and Insights”Ann. Rev. Immunol. 14:649-683 (1996).
Banner et al., “Crystal Structure of the Soluble Human 55 kd TNF Receptor-Human TNFβ Complex: Implications for TNF Receptor Activation”Cell73:431-445 (1993).
Barr and Tomei, “Apoptosis and Its Role in Human Disease”Bio/Technology12:487-493 (1994).
Bayes et al., “The anhidrotic ectodermal dysplasia gene (EDA) undergoes alternative splicing and encodes ectodysplasin-A with deletion mutations in collagenous repeats”Human Molecular Genetics7(11) :1661-1669 (Oct. 1998).
Bodmer et al., “TRAMP, A Novel Apoptosis-Mediating Receptor with Sequence Homology to Tumor Necrosis Factor Receptor 1 and Fas(Apo-1/CD95) .”Immunity. 6:79-88 (1997).
Boldin et al., “Involvement of MACH, a Novel MORTI/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor-Induced Cell Death”Cell85:803-815 (1996).
Boldin et al., “Self-Association of the “Death Domains” of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects”Journal of Biological Chemistry270:387-391 (1995).
Bolivar et al., “Construction and Characterization of New Cloning Vehicles. II. A Multipurpose Cloning System”Gene2:95-113 (1977).
Brockhaus et al., “Identification of Two Types of Tumor Necrosis Factor Receptors on Human Cell Lines by Monoclonal Antibodies.”Proc. Natl. Acad. Sci. USA87:3127-3131 (1990).
Brojatsch et al., “CAR1, A TNFR-Related Protein, Is a Cellular Receptor for Cytopathic Avian Leukosis-Sarcoma Viruses and Mediates Apoptosis.”Cell. 87:845-855 (1996).
Browning et al., “Lympotoxin β, a Novel Member of the TNF Family That Forms a Heteromeric Complex with Lymphotoxin on the Cell Surface”Cell72:847-856 (1993).
Cao et al., “IRAK: a kinase associated with the interleukin-1 receptor”Science271(5252) :1128-1131 (Feb. 23, 1996).
Chicheportiche et al., “TWEAK, A New Secreted Ligand in the Tumor Necrosis Factor Family that Weakly Induces Apoptosis.”Journal of Biological Chemistry272(51) :32401-32410 (1997).
Chinnaiyan and Dixit, “The Cell-Death Machine”Current Biology6:555-562 (1996).
Chinnaiyan et al., “FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis”Cell81:505-512 (1995).
Chinnaiyan et al., “FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced Apoptosis”Journal of Biological Chemistry271:4961-4965 (1996).
Chinnaiyan et al., “Interaction of CED-4 with CED-3 and CED-9: A Molecular Framework for Cell Death”Science275:1122-1126 (1997).
Chinnaiyan et al., “Signal Transduction by DR3. A Death Domain-Containing Receptor Related to TNFR-1 and CD95.”Science. 274:990-992 (1996).
Cleveland and Ihle, “Contenders in FasL/TNF Death Signaling”Cell81:479-482 (1995).
Dealtry et al., “DNA Fragmentation and Cytotoxicity Caused by Tumor Necrosis Factor is Enhanced by Interferon-γ”European Journal of Immunology17:689-693 (1987).
Degli-Esposti et al., “Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family”Journal of Experimental Medicine186(7) :1165-1170 (1997).
Degli-Esposti et al., “The Novel Receptor TRAIL-R4 Induces NF-kB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain”Immunity7:813-820 (1997).
Enari et al., “Involvement of an ICE-like protease in Fas-mediated Apoptosis”Nature375:78-81 (1995).
Fraser and Evan, “A License to Kill”Cell85:781-784 (1996).
Golstein, P., “Cell Death: TRAIL and its Receptors”Curr. Biol7:R750-R753 (1997).
Goodwin et al., “Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor”Cell73(3) :447-456 (May 7, 1993).
Goodwin et al., “Molecular Cloning and Expression of the Type 1 and Type 2 Murine Receptors for Tumor Necrosis Factor.”Mol. Cell. Bio. 11:3020-3026 (1991).
Goodwin et al., “Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor”European Journal of Immunology23(10) :2631-2641 (Oct. 1993).
Gruss and Dower, “Tumor Necrosis Factor Ligand Superfamily: Involvement in the Pathology of Malignant Lymphomas”Blood85:3378-3404 (1995).
Gurney et al., “Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR”Current Biology9(4) :215-218 (Feb. 25, 1999).
Hahne et al., “APRIL, A New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth.”Journal of Experimental Medicine188(6) :1185-1190 (1998).
Hale et al., “Demonstration of In Vitro and In Vivo Efficacy of Two Biologically Active Human Soluble TNF Receptors Expressed inE. coli.”J. Cell Biochem. (abstract only, suppl. 15F; p. 424) pp. 113 (1991).
Harbury et al., “A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants”Science262(5138) :1401-1407 (Nov. 26, 1993).
Hohmann et al., “Two different cell types have different major receptors for human tumor necrosis factor (TNFα)”Journal of Biological Chemistry264(25) :14927-14934 (1989).
Holmes et al., “Structure and Functional Expression of a Human Interleukin-8 Receptor”Science253 (5025) :1278-1280 (1991).
Hsu et al., “TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways”Cell84 :299-308 (1996).
Hu et al., “Characterization of TNFRSF19, a novel member of the tumor necrosis factor receptor superfamily”Genomics62(1) :103-107 (Nov. 15, 1999).
Ytoh et al., “The Polypeptide Encoded by the cDNA for Human Cell Surface Antigen Fas Can Mediate Apoptosis.”Cell. 66:233-243 (1991).
Johnson et al., “Expression and Structure of the Human NGF Receptor”Cell47:545-554 (1986).
Kere et al., “X-linked anhidrotic (hypohidrotic) ectoderm
Goddard Audrey
Pan James
Yan Minhong
Dreger Ginger R.
Genentech Inc.
Heller Ehrman LLP
Marschang Diane L.
O'Hara Eileen B.
LandOfFree
Nucleic acids encoding a tumor necrosis factor homolog does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acids encoding a tumor necrosis factor homolog, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids encoding a tumor necrosis factor homolog will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3731603